Kaletra and Flonase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kaletra (lopinavir; ritonavir) and Flonase (fluticasone propionate). Common drug interactions include depression among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Kaletra and Flonase. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Kaletra?

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. eHealthMe is studying from 23,070 Kaletra users. Check the latest studies of Kaletra.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.



On Jul, 10, 2026

50 people who take Kaletra and Flonase together, and have interactions are studied.

Kaletra and Flonase drug interactions.

What are the common drug interactions of Kaletra and Flonase, by gender? *:

female:

  1. Depression
  2. Fall
  3. Glomerular filtration rate decreased
  4. Humerus fracture (injury to the upper arm bone)
  5. Multiple fractures
  6. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Vitamin d deficiency
  9. Abdominal pain upper
  10. Acute respiratory failure

male:

  1. Anxiety
  2. Emotional distress
  3. Nervousness
  4. Neuropathy peripheral (surface nerve damage)
  5. Renal transplant
  6. Renal tubular disorder (disease of kidney tubules)
  7. Adrenal suppression (suppression of cortisol secretion by the adrenal glands)
  8. Alanine aminotransferase increased
  9. Anger
  10. Aspartate aminotransferase increased

What are the common drug interactions of Kaletra and Flonase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Alanine aminotransferase abnormal
  2. Aspartate aminotransferase abnormal
  3. Bone density decreased
  4. Nephrolithiasis (calculi in the kidneys)

20-29:

n/a

30-39:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Herpes virus infection
  3. Hyperglycaemia (high blood sugar)
  4. Oral candidiasis (fungal infection of mouth)
  5. Tinea infection (fungal skin infection)
  6. Type 2 diabetes mellitus
  7. Acute respiratory failure
  8. Death
  9. General physical health deterioration (weak health status)
  10. H1n1 influenza (flu (influenza), which is caused by virus influenza a (h1n1))

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Pain
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Foot fracture
  8. Bone density decreased
  9. Osteoporosis (bones weak and more likely to break)
  10. Renal transplant

50-59:

  1. Depression
  2. Foot fracture
  3. Anger
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Arthralgia (joint pain)
  7. Emotional distress
  8. Haemolytic anaemia (anaemia due to haemolysis)
  9. Homicidal ideation (thoughts about human killing another human)
  10. Hypoaesthesia (reduced sense of touch or sensation)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Pain
  4. Pneumonia
  5. Renal failure (kidney dysfunction)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Staphylococcal infection (an infection with staphylococcus bacteria)
  9. Bacteraemia (presence of bacteria in the blood)
  10. Chronic kidney disease

What are the existing conditions these people have? *

  1. Hiv Infection: 31 people, 62.00%
  2. High Blood Pressure: 5 people, 10.00%
  3. Stress And Anxiety: 3 people, 6.00%
  4. Insomnia (sleeplessness): 3 people, 6.00%
  5. Hypersensitivity: 3 people, 6.00%
  6. High Blood Cholesterol: 3 people, 6.00%
  7. Diabetes: 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Kaletra and Flonase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kaletra and Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kaletra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kaletra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flonase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lopinavir; ritonavir and fluticasone propionate (the active ingredients of Kaletra and Flonase, respectively), and Kaletra and Flonase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: